Cancer therapeutics

#Cancer drug targets #Cancer research #Cancer therapeutics #FDA #Oncology

New DDW Highlights podcast: 19 August 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. The chosen news highlights this week all feature advances in drug development in oncology… Read More

#News

#Cancer drug targets #Cancer research #Cancer therapeutics #FDA #Oncology

New DDW Highlights vodcast: 19 August 2024

Every week, DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates in the DDW Highlights podcast. It is now also available in a concise vodcast format.   The chosen news highlights this… Read More

#News

#Cancer drug targets #Cancer research #Cancer therapeutics #FDA #Oncology

This week in drug discovery (12-16 August) 

News round-up for 12-16 August by DDW Senior Digital Content Editor Diana Spencer. The chosen news highlights this week all feature advances in drug development in oncology indications and reflect the breadth of therapeutic approaches to cancer treatment. The top stories: Genetic causes of… Read More

#News

#Cancer research #Cancer therapeutics #Haematology #Oncology

New DDW Highlights vodcast: 31 July 2024

Every week, DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates in the DDW Highlights podcast. It is now also available in a concise vodcast format.   There have been some interesting… Read More

#News

#Cancer research #Cancer therapeutics #Haematology #Oncology

New DDW Highlights vodcast: 23 July 2024

Every week, DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates in the DDW Highlights podcast. It is now also available in a concise vodcast format.   The chosen news stories this… Read More

#News

#Cancer research #Cancer therapeutics #Haematology #Oncology

New DDW Highlights podcast: 22 July 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. The chosen news stories this week all feature therapies that could have significant… Read More

#News

#Cancer research #Cancer therapeutics #Haematology #Oncology

This week in drug discovery (15-19 July) 

News round-up for 15-19 July by DDW Senior Digital Content Editor Diana Spencer. The chosen news stories this week all feature therapies that could have significant impact on the future treatment of cancer, particularly haematological malignancies, but also solid tumours. The top stories:… Read More

#News

#ASCO #Cancer research #Cancer therapeutics #Oncology

New DDW Highlights podcast: 11 June 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  With the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting concluding this week,… Read More

#News

#ASCO #Cancer research #Cancer therapeutics #Oncology

This week in drug discovery (3-7 June) 

News round-up for 3-7 June by DDW Senior Digital Content Editor Diana Spencer. With the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting concluding this week, the headline news has all focused on breakthrough cancer research shared at the event. The top stories:… Read More

#News

Cancer cells
#ASCO #Cancer therapeutics #Cancer treatment #Cancer vaccine #Oncology

Five 2024 breakthroughs in cancer drug research

With the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from 30 May to 3 June, the drug discovery announcements have been coming thick and fast, with many new cancer therapies making significant strides forward in our ability to treat the disease. Lorbrena advances… Read More

#Cancer Research #News #Trending News

#AACR #Cancer immunotherapy #Cancer research #Cancer therapeutics #Oncology

New DDW Highlights podcast: 15 April 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The cancer research news has been coming thick and fast from the American Association… Read More

#News

#AACR #Cancer immunotherapy #Cancer research #Cancer therapeutics #Oncology

This week in drug discovery (8-12 April) 

News round-up for 8-12 April by DDW Digital Content Editor Diana Spencer. The cancer research news has been coming thick and fast from the American Association of Cancer Research (AACR) Annual Meeting in San Diego this week, so our Friday round-up focuses on drug discovery in oncology. Read More

#News

FDA headquarters
#Cancer research #Cancer therapeutics #FDA #Oncology

Study casts doubt on benefit of ‘accelerated approval’ cancer drugs

More than 40% of cancer drugs granted accelerated approval from 2013 to 2017 did not demonstrate clinical benefit in confirmatory trials, according to a study in the Journal of the American Medical Association (JAMA). The paper ‘Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval’ reviewed 46 drugs… Read More

#Editor's Choice #News #Regulatory

#Biomanufacturing #Biopharma #Cancer therapeutics #Drug discovery #Immutep #LAG-3

New podcast: Important therapies for the future of immunotherapy

This is the latest episode of the free DDW narrated podcast, “Important therapies for the future of immunotherapy”, which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “Improving quality control for CAR T cell therapies”, and… Read More

#News

Cancer immunotherapy
#Cancer therapeutics #Immutep #LAG-3

The importance of LAG-3 to the future of immunotherapy

Listen to this article on the DDW Podcast: Immutep is working to understand and develop therapeutics that relate to Lymphocyte Activation gene-3 or ‘LAG-3’ which is a cell surface molecule that plays a vital role in regulating the immune system. LAG-3 was discovered by Frederic Triebel, CSO, Immutep, putting the company… Read More

#Exclusive Content